🇺🇸#REGN #отчетность
Regeneron
- Adj EPS $11.86 (Est. $10.77)
- Sales $3.43B (Est. $3.29B)
- Forecasts 2024 Adjusted R&D Expenses Of $4.3B-$4.5B And Adjusted SG&A Expenses Of $2.5B-$2.65B
Regeneron
- Adj EPS $11.86 (Est. $10.77)
- Sales $3.43B (Est. $3.29B)
- Forecasts 2024 Adjusted R&D Expenses Of $4.3B-$4.5B And Adjusted SG&A Expenses Of $2.5B-$2.65B